A detailed history of Bank Of Montreal transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 287,610 shares of COGT stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287,610
Holding current value
$2.26 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$8.24 - $11.48 $2.37 Million - $3.3 Million
287,610 New
287,610 $3.11 Million
Q4 2021

Feb 11, 2022

SELL
$7.51 - $10.81 $989,495 - $1.42 Million
-131,757 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.99 - $9.14 $789,224 - $1.2 Million
131,757 New
131,757 $1.16 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $517M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.